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Abstract
OBJECTIVE: To observe the effect of decoction for
reinforcing lung Qi on T-lymphocytic function, in-
terleukin-2 (IL-2) and tumor necrosis factor-α
(TNF-α) in peripheral blood of patients with
non-small cell lung cancer after operation with ar-
gon helium lancet in order to explore its mecha-
nism.
METHODS: A total of 76 patients suffering from
non-small cell lung cancer without surgical indica-
tion were randomly divided into a treatment group
treated with decoction for reinforcing lung Qi and
argon helium lancet and a control group treated
with argon helium lancet only to observe lympho-
cytic proliferation, detect the percentage of posi-
tive cells in the T-lymphocyte CD28with flow cytom-
etry and detect the expression of IL-2 and TNF-α in
peripheral blood with enzyme linked immunosor-
bent assay.
RESULTS: Proliferation of T-lymphocytes and ex-
pression of CD28, IL-2 and TNF-α in peripheral blood
after treatment in the treatment group were more
obviously strengthened than those before treat-
ment and those in the control group (all P<0.05).
CONCLUSION: The mechanism of using decoction
for reinforcing lung Qi and argon helium lancet to
treat lung cancer may be realized through promot-
ing T-lymphocytic proliferation, up-regulating ex-
pression of CD28, IL-2 and TNF-α, and activating
T-cells.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Non-small cell lung cancer is one of the lung cancers
commonly seen in clinical practice. Patients without
surgical indication are often treated with chemothera-
py, radiotherapy, target therapy and micro-traumatic
operation. Argon helium lancet, a new technique of mi-
cro-traumatic surgery, under ultralow temperature, can
cause necrosis of cancerous cells, lighten tumor load
and control progress of local tumor.1,2 The mechanism
of cell death in target area lies in hypoxia jointly caused
by formation of icy crystal inside and outside cells, cell
dehydration, concentration of electrolytic toxicity and
rupture of micrangium.3 The curative effect of Chinese
herbs on lung cancer has been widely accepted.4-6
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When using Chinese herb and argon helium lancet to
treat patients with non-small cell lung cancer, we have
discovered that their symptoms are obviously improved
and their survival quality is noticeably enhanced.7 Re-
searches have shown that the generation and develop-
ment of malignant tumor are closely related to the im-
mune function of cells.8-10 Our previous clinical re-
searches have also confirmed that Chinese herbs can en-
hance the immunity of lung cancer patients.11 In this
study, through using Chinese herb and argon helium
lancet to treat inpatients with non-small cell lung can-
cer that can not be treated with surgical operation, we
observed changes in T-cell function, IL-2 and TNF-α
in peripheral blood after treatment and investigated
the therapeutic mechanism of Chinese herb and argon
helium lancet in patients with non-small cell lung can-
cer.
MATERIALS ANDMETHODS
Diagnosis criteria
Diagnosis Criteria in Western Medicine: non-small cell
lung cancer is pathologically diagnosed in biopsy with
tracheoscopy or with pneumocentesis guided by CT.
Diagnosis criteria in Traditional Chinese Medicine: In
reference to the criteria for diagnosing deficiency of
lung Qi in the Principle on Directing Clinical Re-
searches into New Chinese Herbs issued in 2002,12 ma-
jor symptoms are cough with weak voice, asthma,
short breath and common cold, and minor symptoms
are lingering cough, spontaneous perspiration, aversion
to wind, lassitude, unwillingness to talk, pale tongue
and weak pulse. Patients with 2 major symptoms and 2
minor symptoms or with 1 symptom and 3 minor
symptoms can be diagnosed as suffering from
non-small cell lung cancer.
Inclusion and exclusion criteria
Inclusion criteria: (a) Patients conform to the
above-mentioned criteria of diagnosis in Western medi-
cine and in traditional Chinese medicine. (b) Patients
are 35-75 years old. (c) Karpofsky (KPS) score ≥60 in
reference to the score-evaluating criteria in medical
manual of clinical lung cancer (5th edition).13 (d) Natu-
ral survival time is expected to be more than 3 months.
Exclusion criteria: (a) Patients have undergone exci-
sion. (b) Patients have serious dysfunction of the heart,
lung, liver or kidney. (c) Patients suffer from accumu-
lated liquid in the chest or cancerous lymphangitis. (d)
Patients have accepted radiotherapy and chemotherapy
in the latest month or are orally taking immune-regu-
lating herb. (e) Patients took part in other clinical re-
search within 3 months before inclusion.
Rejection and dropout criteria
Rejection criteria: (a) Patients who do not conform to
criteria of inclusion are erroneously included. (b) Pa-
tients are not treated with this therapy.
Dropout criteria: (a) Patients with serious adverse inci-
dent are unsuitable for continuing this therapy. (b) Pa-
tients with sudden serious diseases or complications are
unsuitable for continuing this therapy. (c) Testees with
poor obedience can not guarantee to complete the re-
search.
Patients and groupings
A total of 76 inpatients with non-small cell lung cancer
at our department from July 2008 to June 2012 were
randomly divided into a treatment group treated with
Chinese herb and argon helium lancet and a control
group treated with argon helium lancet only, with each
38 cases. In the treatment group 22 males and 16 fe-
males aged 36-72 years, (56±8) years on average were
included, while in the control group 24 males and 14
females aged 39-73 years, (57 ± 8) years on average.
There was no statistically significant difference (P>
0.05) in sex, age and KPS score between the 2 groups.
Patients in the control group were treated with argon
helium lancet (Galil Medical Ltd., Yokneam, Israel) un-
der ultralow temperature. After the skin had been local-
ly anaesthetized, the puncture needle monitored by CT
(Koninklijke Philips N. V., Amsterdam, Netherlands)
was thrust into scheduled site, and then argon helium
lancet was inserted. The freezing system was started to
make the temperature at the lancet tip rapidly reduce
to 130℃-150℃ below zero, and the refrigeration was
kept for 10-30 min according to the size of tumor and
its sensitivity to temperature. Monitored by CT, the
size of icy balls was controlled through the control of
flow. Helium (Beijing Praxair Application Gas Co.
Ltd., Beijing, China) was started to raise the tempera-
ture to 0℃ to melt icy balls. Then, refrigeration and
raising temperature were repeated once again. When
the temperature rose to 15℃ , withdrawal of knife was
followed by disinfection, hemostasis and bandaging at
puncture site. While the operation was being carried
out, life signs, electrocardiogram and saturation of
blood oxygen were monitored. The treatment group
was treated with Chinese herb and argon helium lan-
cet. Three days before operation with argon helium lan-
cet, patients began orally taking the decoction for rein-
forcing lung Qi. Its recipe consists of Sheng Huangqi
(Radix Astragali seu Hedysari) 20 g, Dangshen (Radix
Codonopsis Pilosulae) 15 g, Maidong (Radix Ophiopogo-
nis) 15 g, Wuweizi (Fructus Schisandrae) 8 g, Fuling
(Poria) 15 g, Chaobaizhu (Rhizoma Atractylodis Macro-
cephalae) 15 g, Zhigancao (Radix Glycyrrhizae Praepara-
ta) 6 g, Zhebeimu (Bulbus Fritillariae Thunbergii) 10 g
and Baihe (Bulbus lilii) 10 g. The decoction was orally
taken, one dose a day in 2 times, for 10 days. This re-
search was approved by the ethical committee of Gener-
al Hospital of People's Liberation Army. All the pa-
tients have signed informed consent.
Outcome measures
In reference to the method in the article,14 3 days be-
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fore treatment with argon helium lancet and 7 days af-
ter the operation, blood samples were collected respec-
tively from peripheral vein. Absorbent cotton column
was used to separate, purify and culture T-lymphocytes
in peripheral blood. After culture fluid had been pro-
cessed with anti-human CD28mAb (Sigma-Aldrich Co.
LLc., St. Louis, MO, USA), flow cytometry (Becton,
Dickinson and Company, Franklin Lakes, NJ, USA)
was used to detect the expressive rate of positive CD28.
According to the manipulation in manual of kit (Bei-
jing North Institute of Biological Technology, Beijing,
China), the expression of IL-2 and TNF-α in peripher-
al blood was determined.
Safety indices include heart rate, blood pressure, blood
routine, urine routine, function of liver and kidney,
blood sugar and electrocardiogram of patients before
and after treatment. Adverse incident was observed dur-
ing treatment and in one month of follow-up visit.
Statistical analysis
SPSS 12.0 software (SPSS Inc., Chicago, IL, USA) is
used. Measurement data is expressed with mean±stan-
dard deviation ( xˉ ±s) between the 2 groups. Paired t
test is used for comparison inside a group. Grouping
t test is used for comparison between the 2 groups.
P<0.05 means having statistical significance.
RESULTS
Peripheral blood T-lymphocytic proliferation, CD28
positive rate, and IL-2 and TNF-α expressions
All the 76 patients in the 2 groups completed the treat-
ment with argon helium lancet or Chinese herb with-
out rejection or dropout. The T-lymphocytic prolifera-
tion index was 0.57±0.24, CD28 positive rate 70.4％±
11.3％ , IL-2 (91.8 ± 16.0) ng/L and TNF-α (128.2 ±
24.3) ng/L after treatment in the treatment group with
significant difference (P<0.05) from those before treat-
ment and in the control group (Table 1).
Safety and adverse reaction evaluation
Before and after treatment, patients in the 2 groups
had normal heart rate and blood pressure, normal in-
dexes of blood routine, urine routine, hepatic and renal
function, blood sugar and electrocardiogram, without
palpitation, chest pain and other uncomfortable sensa-
tions. Patients in the 2 groups had no adverse reaction
during treatment and in one month of follow-up visit.
DISCUSSION
Researches have shown that the generation of lung can-
cer is closely related to the immune function of the
body.15,16 Argon helium lancet is a new micro-traumatic
surgical operation used to treat lung cancer patients
without surgical indication. Specific antigens produced
by tumor cells destroyed by refrigeration can stimulate
the proliferation of CTL and DC cells and make the
body produce specific anti-tumor immunity to further
inhibit tumor.17 In recent years, great progress has been
made in the researches into mechanism of using tradi-
tional Chinese medicine to treat lung cancer. Especial-
ly, the regulation of human immune function has in-
volved changes in activation of immune cells (includ-
ing T-lymphocytes, red cells and NK cells) and in the
expression of immune cell factors (such as IL-1, IL-2
and TNF-α) and tumor antigens.18-20
So far, there have been some researches into using Chi-
nese herb and argon helium lancet to treat lung cancer,
and few articles on research into the effect of Chinese
herb on immune function of patients treated with ar-
gon helium lancet. According to theory of Traditional
Chinese Medicine, we believe that after surgical opera-
tion or micro-traumatic operation on lung cancer, dam-
age to the lung and deficiency of the lung Qi are the
most fundamental pathogenesis, and patients mainly
have cough, oppressed feeling in the chest, lassitude,
short breath and other clinical symptoms. Therefore,
according to the fundamental pathogenesis, we have
treated patients with method for reinforcing the lung
Qi. In the recipe, Shenghuangqi (Radix Astragali seu
Hedysari) for greatly reinforcing primordial Qi is the
monarch herb. Dangshen (Radix Codonopsis Pilosulae),
Baizhu (Rhizoma Atractylodis Macrocephalae) and Ful-
ing (Poria) for strengthening the spleen and reinforcing
Qi are minister herbs. Maidong (Radix Ophiopogonis),
Baihe (Bulbus lilii), Zhebeimu (Bulbus Fritillariae
Thunbergii) and Wuweizi (Fructus Schisandrae) for
nourishing the lung-yin and stopping cough are adju-
vant herbs. Zhigancao (Radix Glycyrrhizae Praeparata)
Group
Control group
Treatment group
Before treatment
After treatment
Before treatment
After treatment
n
38
38
38
38
Cell proliferation index
0.2±0.2
0.4±0.2a
0.2±0.2
0.6±0.2ab
IL-2 (ng/L)
37.1±9.2
56.5±10.6a
36.9±9.4
70.4±11.3ab
CD28(％)
28.2±6.1
61.8±12.7a
27.8±5.9
91.8±16.0ab
TNF-α (ng/L)
89.2±16.9
112.3±20.4a
88.9±16.5
128.2±24.3ab
Table 1 Comparison of peripheral blood T-lymphocytic proliferation, CD28 positive rate, and IL-2 and TNF-α expressions between
the 2 groups ( xˉ ± s )
Notes: Control group: treated by Argon Helium Cryoablation; Treatment group: treated by decoction for reinforcing lung Qi combined
with Argon Helium Cryoablation. IL-2: interleukin-2; TNF-α: tumor necrosis factor-α. aP<0.05, as compared with the same group before
treatment; bP<0.05, as compared with the control group after treatment.
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for regulating the other herbs is conductant herb. The
whole recipe has the effect of reinforcing the lung Qi
and stopping cough. Modern pharmacology has also
confirmed that Huangqi (Radix Astragali seu Hedysari),
Dangshen (Radix Codonopsis Pilosulae) and other herbs
can obviously strengthen the immune function of pa-
tients to take effect of strengthening the body resis-
tance to resist cancer.21-23
Previous researches have shown that T-lymphocytic pro-
liferation can kill tumor.24 The combination of CD28
with B7-1 or B7-2 can provide coordinated stimulant
signal for the activation of T-lymphocytes. Without co-
ordinated stimulant signal, T-lymphocytes may wither
or enter the state of no inducing ability.25 IL-2 mainly
produced by activated TH1 cells can promote T-lym-
phocytic proliferation, induce Lak cells, promote the
killing effect of T-lymphocytes and strengthen the acti-
vation of NK cells. IL-2 and its receptor system, an im-
portant index reflecting the immune function of the
body,26 play an important role in resisting tumor.
TNF-α, a multi-functional cell factor mainly secreted
by TH1 cells and an important tumor-killing medium
of mononuclear cells and macrophages, can directly
kill and inhibit tumor cells.27,28
This research shows that decoction for reinforcing lung
Qi and argon helium lancet can more obviously
strengthen T-lymphocytic proliferation and increase
the expression of CD28 molecules on the surface and
IL-2 and TNF-α in peripheral blood of patients with
non-small cell lung cancer than argon helium lancet
alone. The anticancer effect of this method may be
caused by strengthening the coordinated stimulant sig-
nal of T-lymphocytes, increasing the coordinated stimu-
lant signal of antigen cells and T-lymphocytes, enhanc-
ing the activation of T-lymphocytes, secreting more cell
factors with anti-tumor effect, and giving play to the
network effect of cell factors and the toxic effect of
T-lymphocytes.
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